300
Views
5
CrossRef citations to date
0
Altmetric
Review

Direct bronchoprovocation test methods: history 1945–2018

, &
Pages 279-289 | Received 18 Oct 2018, Accepted 08 Jan 2019, Published online: 24 Jan 2019

References

  • Cockcroft DW. Understanding the clinical usefulness of airway hyperresponsiveness. Clin Asthma Rev. 1997;1:63–70.
  • Pauwels R, Joos G. Van der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy. 1988;18:317–321.
  • Joos GF, O’Connor B, Anderson SD, et al. Indirect airway challenges. Eur Respir J. 2003;21:1050–1068.
  • Cockcroft D, Davis B. Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol. 2009;103(5):363–369.
  • Sneader W. Drug discovery: a history Chichester, UK: John Wiley & Sons; 2005. p. 98–99.
  • Tansey EM. Henry Dale and the discovery of acetylcholine. C R Biol. 2006;329(5–6):419–425.
  • Major RT, Cline JK. Preparation and properties of alpha- and beta-methylcholine and gamma-homocholine. J Am Chem Soc. 1932;54:242–249.
  • Dale HH, Laidlaw PP. The physiological action of beta-iminazolylethylamine. J Physiol. 1910;41(5):318–344.
  • Alexander HL, Paddock R. Bronchial asthma: response to pilocarpin and epinephrin. Arch Intern Med. 1921;27:184–191.
  • Weiss S, Robb GP, Blumgart HL. The velocity of blood flow in health and disease as measured by the effect of histamine on the minute vessels. Am Heart J. 1929;4:664–691.
  • Starr I Jr., Elsom KA, Reisinger JA, et al. Acetyl-β-methylcholin. Am J Med Sci. 1933;186(3):313–323.
  • Villaret M, Vallery-Radot P, Justin-Besancon L, et al. Recherches préliminaires sur les crises provoquées chez les asthmatiques par certains esters de la choline [Preliminary research on attacks in asthmatics provoked by certain choline esters]. C R Soc Biol. 1934;116:1343–1346. French
  • Moll HH. The action of parasympathetic-mimetic drugs in asthma. Q J Med. 1940;9:229.
  • Dautrebande L, Philippot E. Crise d’asthme expérimental par aérosols de carbaminoylcholine chez l’homme traitée par dispersat de phénylaminopropane [Experimental asthma attack produced by aerosols of carbiminoylchoiline in men treated with phenylaminopropane]. Press Méd. 1941;49:942–946. French.
  • Tiffeneau R, Beauvallet M. Broncho-constriction par aérosols acétyl-cholinques. Test pour la mesure de l’insuffisance respiratoire [Bronchoconstriction by acetyl choline aerosols: test for measuring respiratory insufficiency]. Bull Mém Soc Med. des Hȏpitaux de Paris. 1945;61:107–108. French.
  • Tiffeneau R, Beauvallet M. Epreuves de broncho-constriction et de broncho-dilatation. Emploi pour le dépistage, la mesure et le contrȏle des insuffisances respiratoires chroniques [Test of bronchoconstriction and of bronchodilation by aerosols: use for the screening, measurement and control of chronic respiratory insufficiency]. Bull Acad Méd. 1945;129:165–168. French.
  • Tiffeneau R, Pinelli A. Air circulant et air captif dans l’exploration de la fonction ventilatrice pulmonaire [Circulating air and captive air in the exploration of lung ventilatory function]. Paris Méd. 1947;37(52):624–628. French.
  • Tiffeneau R, Drutel P. Les aérosols d’acétylcholine dans l’exploration fonctionelle des poumons [Acetylcholine aerosols in respiration function tests; study of their motor and sensory effects; practical application]. Poumon Coeur. 1955;11(5): 385–468. French.
  • Tiffeneau R. L’hyperexcitabilité acétylcholinique du poumon critère physio-pharmacodynamique de la maladie asthmatique [Acetylcholine hyperexcitability of the lung; physiopharmacodynamic criterion in asthma]. Presse Méd. 1955;16:63(12): 227–230. French.
  • Tiffeneau R. Hypersensibilité cholinergo-histaminique pulmonaire de l’asthmatique [Cholinergic-histaminic pulmonary hypersensitivity of asthma; relationship with pulmonary allergen hypersensitivity]. Acta Allergol Suppl (Copenh). 1958;5:187–221. French.
  • Juniper EF, Frith PA, Dunnett C, et al. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax. 1978;33:705–710.
  • Cockcroft DW, Ruffin RE, Frith PA, et al. Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis. 1979;120:1053–1058.
  • Similowski T, Doré MF, Marazzini L, et al. Expiration forcée: quelques concepts actuels, 50 ans après Robert Tiffeneau [Forced expiration. Various current concepts, 50 years after Robert Tiffeneau]. Rev Mal Respir. 1997;14(6):431–443. French.
  • Curry JJ. The action of histamine on the respiratory tract in normal and asthmatic subjects. J Clin Invest. 1946;25:785–791.
  • Curry JJ. Comparative action of acetyl-beta-methylcholine and histamine on the respiratory tract in normals, patients with hayfever and subjects with bronchial asthma. J Clin Invest. 1947;26:430–438.
  • Curry JJ, Lowell FC. Measurement of vital capacity in asthmatic subjects receiving histamine and acetyl-beta-methylcholine - a clinical study. J Allergy. 1948;19:9–18.
  • de Vries K, Goei JT, Booy-Noord H, et al. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy. 1962;20:93–101.
  • de Vries K, Booij-Noord H, Goei JT, et al. Hyperreactivity of the bronchial tree to drugs, chemical and physical agents. In: Orie NGM, Sluiter HJeditors. Bronchitis II. The Netherlands: Royal VanGorcum, Assen; 1964. p. 167–180.
  • Altounyan REC. Variation of drug action on airway obstruction in man. Thorax. 1964;19:406–415.
  • Makino S. Clinical significance of bronchial sensitivity to acetylcholine and histamine in bronchial asthma. J Allergy. 1966;38:127–142.
  • Townley RG, Dennis M, Itkin IH. Comparative action of acetyl-beta-methylcholine, histamine, and pollen antigens in subjects with hay fever and patients with bronchial asthma. J Allergy. 1965;36:121–137.
  • Parker CD, Bilbo RE, Reed CE. Methacholine aerosol as test for bronchial asthma. Arch Intern Med. 1965;115:452–458.
  • Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax. 1983;38:760–765.
  • Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975;56:323–327.
  • Empey DW, Laitinen LA, Jacobs L, et al. Mechanisms of bronchial hyperreactivity in normal subjects after upper airway respiratory tract infection. Am Rev Respir Dis. 1976;113:131–139.
  • Spector SL, Farr RS. Bronchial inhalation procedures in asthmatics. Med Clin North Am. 1974;58:71–84.
  • Cockcroft DW. Measurement of airway responsiveness to inhaled histamine or methacholine: method of continuous aerosol generation and tidal breathing inhalation. In: Hargreave FE, Woolcock AJ, editors. Airway responsiveness: Measurement and Interpretation. Ontario, Canada: Astra Pharmaceuticals Canada Ltd.; 1985. p. 22–28.
  • Dehaut P, Rachiele A, Martin RR, et al. Histamine dose-response curves in asthma: reproducibility and sensitivity of different indices to assess response. Thorax. 1983;38:516–522.
  • Cockcroft DW, Killian DN, Mellon JJA, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235–243.
  • Beaupré A, Malo JL. Comparison of histamine bronchial challenges with the wright nebulizer and the dosimeter. Clin Allergy. 1979;9(6):575–583.
  • Ryan G, Dolovich MB, Roberts RS, et al. Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis. 1981;123:195–199.
  • Salome CM, Schoeffel RE, Woolcock AJ. Comparison of bronchial reactivity to histamine and methacholine in asthmatics. Clin Allergy. 1980;10(5):541–546.
  • Juniper EF, Syty-Golda M, Hargreave FE. Histamine inhalation tests: inhalation of aerosol via a facemask versus a valve box with mouthpiece. Thorax. 1984;39:556–557.
  • Ryan G, Dolovich MB, Obminski G, et al. Standardization of inhalation provocation tests: influence of nebulizer output, particle size and method of inhalation. J Allergy Clin Immunol. 1981;67:156–161.
  • Cockcroft DW, Berscheid BA. Standardization of inhalation provocation tests: dose vs concentration of histamine. Chest. 1982;82:572–575.
  • Anderton RC, Cuff MT, Frith PA, et al. Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol. 1979;63:315–320.
  • O’Byrne PM, Ryan G, Morris M, et al. Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis. 1982;125:281–285.
  • Juniper EF, Frith PA, Hargreave FE. Airways responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax. 1981;36:575–579.
  • Ryan G, Latimer KM, Dolovich J, et al. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax. 1982;37:423–429.
  • Kirby JG, Hargreave FE, Gleich GJ, et al. Bronchoalveolar cell profiles of asthmatic and non-asthmatic subjects. Am Rev Respir Dis. 1987;136:379–383.
  • Drotar DE, Davis BE, Cockcroft DW. Dose versus concentration of methacholine. Ann Allergy Asthma Immunol. 1999;83:229–230.
  • Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med. 2000;161:309–329.
  • Juniper EF, Cockcroft DW, Hargreave FE. Histamine and methacholine inhalation tests: tidal breathing method - laboratory procedure and standardisation. 2nd ed. Sweden: AB Draco, Lund; 1994.
  • Davis BE, Cockcroft DW. Calculation of provocation causing a 20% fall in FEV1: comparison of lowest vs highest post-challenge FEV1. Chest. 2000;117(3):881–883.
  • Cockcroft DW, Davis BE. Histamine and methacholine challenge cut points. Ann Allergy Asthma Immunol. 2010;104(5):450–451.
  • Wubbel C, Asmus MJ, Stevens G, et al. Methacholine challenge testing: comparison of the two American Thoracic Society-recommended methods. Chest. 2004;125:453–458.
  • Cockcroft DW, Davis BE, Todd DC, et al. Methacholine challenge: comparison of two methods. Chest. 2005;127:839–844.
  • Prieto L, Lopez V, Llusar R, et al. Differences in the response to methacholine between the tidal breathing and dosimeter methods: influence of the dose of bronchoconstrictor agent delivered to the mouth. Chest. 2008;134:699–703.
  • Pelligrino R, Sterk PJ, Sont JK, et al. Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD. Eur Respir Dis. 1998;12(5):1219–1227.
  • Kapsali T, Permutt S, Laube B, et al. Potent bronchoprotective effect of deep inspiration and its absence in asthma. J Appl Physiol. 2000;89:711–720.
  • Scichilone N, Kapsali T, Permutt S, et al. Deep inspiration-induced bronchoprotection is stronger than bronchodilation. Am J Respir Crit Care Med. 2000;162:910–916.
  • Todd DC, Davis BE, Hurst TS, et al. Dosimeter methacholine challenge: comparison of maximal versus submaximal inhalations. J Allergy Clin Immunol. 2004;114:517–519.
  • Allen ND, Davis BE, Hurst TS, et al. Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection. Chest. 2005;128:4018–4023.
  • Cockcroft DW, Davis BE. The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test result. J Allergy Clin Immunol. 2006;117:1244–1248.
  • Orehek J, Nicoli MM, Delpierre S, et al. Influence of the previous deep inspiration on the spirometric measurement of provoked bronchoconstrictinin asthma. Am Rev Respir Dis. 1981;123(3):269–272.
  • Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526.
  • Cockcroft DW, Hurst TS, Gore BP. Importance of evaporative water losses during standardized nebulized inhalation provocation tests. Chest. 1989;96:505–508.
  • Coates AL, Leung K, Dell SD. Developing alternative delivery systems for methacholine challenge tests. J Aerosol Med Pulm Drug Deliv. 2014;27(1):66–70.
  • Dell SD, Bola SS, Foty RG, et al. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers. Ann Am Thorac Soc. 2015;12(3):357–363.
  • El-Gammal AI, Killian KJ, Scime TX, et al. Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the wright nebulizer in adult subjects with asthma. Ann Am Thorac Soc. 2015;12(7):1039–1043.
  • Coates AL, Dell SD, Cockcroft DW, et al. The PD20 but not the PC20 in a methacholine challenge test is device independent. Ann Allergy Asthma Immunol. 2017;118(4):508–509.
  • Blais CM, Cockcroft DW, Veilleux J, et al. Methacholine challenge: comparison of airway responsiveness produced by a vibrating mesh nebulizer versus a jet nebulizer. J Aerosol Med Pulm Drug Deliv. 2018;31(2):88–93.
  • Davis BE, Simonson SK, Blais CM, et al. Methacholine challenge testing: a novel method for measuring PD20. Chest. 2017;152(6):1251–1257.
  • Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway resposiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report of the working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl. 1993;16:53–83.
  • Coates A, Culver B, Cockcroft D, et al. Characterizing nebulizer performance for methacholine challenge tests. Am J Respir Crit Care Med. 2018 Aug 30. Epub ahead of print.
  • Peters GE, Davis BE, Cockcroft DW. Comparison of doubling and quadrupling methacholine concentration regimens using the tidal volume method. Ann Allergy Asthma Immunol. 2011;106(1):74–76.
  • Cockcroft DW, Marciniuk DD, Hurst TS, et al. Methacholine challenge: test-shortening procedures. Chest. 2001;120:1857–1860.
  • Yurach MT, Davis BE, Cockcroft DW. The effect of caffeinated coffee on airway response to methacholine and exhaled nitric oxide. Respir Med. 2011;105(11):1606–1610.
  • Cockcroft DW, Davis BE, Roh Y, et al. Effect of ingested H1 antihistamines on methacholine challenge. J Allergy Clin Immunol. 2015;135(2):579–580.
  • Illamperuma C, Davis BE, Fenton ME, et al. Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine. Ann Allergy Asthma Immunol. 2009;102(5):438–439.
  • Blais CM, Davis BE, Cockcroft DW. Duration of bronchoprotection of the long-acting muscarinic antagonists tiotropium & glycopyrronium against methacholine-induced bronchoconstriction in mild asthmatics. Respir Med. 2016;118:96–101.
  • Blais CM, Davis BE, Cockcroft DW. The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study. Respir Res. 2017;18(1):146.
  • Westbury GLM, Blais CM, Davis BE, et al. Bronchoprotective effect of vilanterol against methacholine-induced bronchoconstriction in mild asthmatics: a randomized three-way crossover study. Ann Allergy Asthma Immunol. 2018;121(3):328–332.
  • O’Byrne PM, van der Linde J, Cockcroft DW, et al. Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma. J Allergy Clin Immunol. 2009;124(6):1217–1221.
  • Davis BE, Cockcroft DW. Effect of a single dose of montelukast sodium on methacholine chloride PC20. Can Respir J. 2005;12(1):26–28.
  • Cockcroft DW, Hargreave FE. Airway hyperresponsiveness: relevance of random population data to clinical usefulness. Am Rev Respir Dis. 1990;142:497–500.
  • Holzer K, Anderson SD, Douglas J. Exercise in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol. 2002;110(3):374–380.
  • Pattemore PK, Asher MI, Harrison AC, et al. The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma and asthma symptoms. Am Rev Respir Dis. 1990;142(3):549–554.
  • Tantisira KG, Colvin R, Tonascia J, et al. Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med. 2008;178(4):325–331.
  • Liem JJ, Kozynskyi AL, Cockcroft DW, et al. Diagnosing asthma in children: what is the role for methacholine bronchoprovocation testing? Pediatr Pulmonol. 2008;43(5):481–489.
  • Schulze J, Smith HJ, Fuchs J, et al. Methacholine challenge in young children as evaluated by spirometry and impulse oscillometry. Respir Med. 2012;106(5):627–634.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.